CATEGORIES

Prejex joins hands with Polybond to make needle-less injections in India
BioSpectrum Asia

Prejex joins hands with Polybond to make needle-less injections in India

Prejex Inc., a spin-off of Germany-based Prejex GMBH, has entered into an agreement with Polybond, headed by Adit Rathi of Rathi Group to manufacture needleless injections.

time-read
1 min  |
January 2023
Thailand develops
BioSpectrum Asia

Thailand develops

speech recognition AI tech for screening depression

time-read
1 min  |
January 2023
Australian first research
BioSpectrum Asia

Australian first research

trial to explore use of psychedelics for alcohol use disorder

time-read
1 min  |
January 2023
AstraZeneca India
BioSpectrum Asia

AstraZeneca India

appoints Dr Sanjeev Panchal as Country President MD

time-read
1 min  |
January 2023
One Health Trust BITS Pilani offer PhD
BioSpectrum Asia

One Health Trust BITS Pilani offer PhD

programme in Data Sciences for global health

time-read
1 min  |
January 2023
NTU Singapore and Imperial College London strengthen ties
BioSpectrum Asia

NTU Singapore and Imperial College London strengthen ties

Building on their successful collaboration in setting up the Lee Kong Chian School of Medicine LKCMedicine), Nanyang Technological University, Singapore NTU Singapore) and Imperial College London have signed a new strategic university-wide partnership to expand their scope of collaboration across research, education, and innovation and enterprise.

time-read
1 min  |
January 2023
Broad-impact Tech Against AMR Threat
BioSpectrum Asia

Broad-impact Tech Against AMR Threat

According to one of the most comprehensive studies of antimicrobial resistance AMR), 95 million deaths were associated with including 1.27 million deaths attributed to bacterial AMR in 20109.

time-read
4 mins  |
January 2023
Al: Tremendous Potential to Transform Bioprocessing Efficiencies
BioSpectrum Asia

Al: Tremendous Potential to Transform Bioprocessing Efficiencies

The biopharmaceutical industry is witnessing unprecedented growth, with a surge in demand for vaccines, monoclonal antibodies mAbs), and advanced modalities including RNA therapeutics, mRNA vaccines, and cell and gene therapies CGTs).

time-read
5 mins  |
January 2023
Propelling Genomic Research with Future-Proof Digital Infrastructure
BioSpectrum Asia

Propelling Genomic Research with Future-Proof Digital Infrastructure

Digital transformation in healthcare has been D at breakneck speed since the outbreak of the COVID-109.

time-read
4 mins  |
January 2023
“We are seeing activity within biotherapeutics market in Southeast Asia’
BioSpectrum Asia

“We are seeing activity within biotherapeutics market in Southeast Asia’

Jason Neo, Director, Marketing J-KOSEA, SCIEX, Singapore

time-read
2 mins  |
January 2023
“Our ambition requires us to take long-term view, investing in scale and building unmatched capabilities”
BioSpectrum Asia

“Our ambition requires us to take long-term view, investing in scale and building unmatched capabilities”

The novel trend in single-cell analysis is revolutionising biological research, unravelling underlying genetic credentials while creating new therapeutic approaches and personalised treatments.

time-read
5 mins  |
January 2023
‘Innovations that serve a purpose, paired with a good go-to-market Strategy are attractive for VCs"
BioSpectrum Asia

‘Innovations that serve a purpose, paired with a good go-to-market Strategy are attractive for VCs"

Singapore’s health and biomedical landscape constitutes a vibrant pool of innovative medical technology, biotechnology and biopharmaceutical entrepreneurship.

time-read
5 mins  |
January 2023
“Crovalimab could potentially become the first global drug originating from Singapore”
BioSpectrum Asia

“Crovalimab could potentially become the first global drug originating from Singapore”

There has been explosive growth in the mid- size molecules and therapeutic antibody market as many cancers, autoimmune diseases, metabolic diseases, and infectious diseases have been successfully treated.

time-read
4 mins  |
January 2023
New Zealand explores
BioSpectrum Asia

New Zealand explores

ways to improve clinical trials

time-read
1 min  |
January 2023
Singapore injects
BioSpectrum Asia

Singapore injects

1M into Global Fund for fighting AIDS, malaria and TB

time-read
1 min  |
January 2023
Japan approves manufacturing and marketing of Adtralza for atopic dermatitis
BioSpectrum Asia

Japan approves manufacturing and marketing of Adtralza for atopic dermatitis

Denmark-based LEO Pharma A/S, a global leader in medical dermatology, has announced that the Japan Ministry of Health, Labour and Welfare (MHLW) has granted approval for the manufacturing and marketing of Adtralza (tralokinumab) subcutaneous injection

time-read
1 min  |
January 2023
Korea, Singapore strengthen bilateral cooperation over digital health medical devices
BioSpectrum Asia

Korea, Singapore strengthen bilateral cooperation over digital health medical devices

South Korean Ministry of Food and Drug Safety (MFDS) recently held a bilateral meeting with the Health Sciences Authority (HSA) of Singapore at Seoul to support the advancement of domestic medical devices into the global market and strengthen bilateral cooperation in the field of digital health medical devices

time-read
1 min  |
January 2023
India Discovers 3 Antiviral Molecules For Treating COVID-19
BioSpectrum Asia

India Discovers 3 Antiviral Molecules For Treating COVID-19

A team of researchers at Indian Institute of Technology (IIT) Roorkee has identified antiviral molecules that can be used effectively to treat COVID-19 infections.

time-read
1 min  |
December 2022
PerkinElmer launches industry-first readyto-use viral vector assays
BioSpectrum Asia

PerkinElmer launches industry-first readyto-use viral vector assays

PerkinElmer, Inc. has launched ready-to-use Adenoassociated Virus Vectors (AAV) Detection Kits to support researchers working on gene therapies for a variety of serious diseases.

time-read
1 min  |
December 2022
Agilent, Monash University collaborate to build Malaysia Integrated Biology Centre
BioSpectrum Asia

Agilent, Monash University collaborate to build Malaysia Integrated Biology Centre

Agilent Technologies has entered a new strategic partnership with Monash University Malaysia (Monash) to build a Malaysia integrated biology centre

time-read
1 min  |
December 2022
Nikon enters into Indian healthcare sector through microscopy biz
BioSpectrum Asia

Nikon enters into Indian healthcare sector through microscopy biz

Nikon India has announced its foray into India’s healthcare sector through System Product Microscopy business.

time-read
1 min  |
December 2022
Sartorius enters research partnership with The BASE Facility at University of Queensland
BioSpectrum Asia

Sartorius enters research partnership with The BASE Facility at University of Queensland

Germany-based Sartorius has entered a research partnership with The BASE Facility at The University of Queensland (UQ), Australia to improve the manufacturing process of nucleic acid products led by the external collaboration group, Separation Separation Technology Marketing team.

time-read
1 min  |
December 2022
Singapore links air polluting particles with cardiac arrests
BioSpectrum Asia

Singapore links air polluting particles with cardiac arrests

Small particles in air pollution in Singapore might have caused sudden cardiac arrests in some people who were not in hospital but simply going about their normal lives, according to scientists at Duke-NUS Medical School working with the National Environment Agency (NEA) as part of the PanAsian Resuscitation Outcomes Study (PAROS).

time-read
1 min  |
December 2022
New Zealand explores genomic sequencing to improve newborns' well-being
BioSpectrum Asia

New Zealand explores genomic sequencing to improve newborns' well-being

Researchers from the University of Auckland’s Liggins Institute in New Zealand are about to harness the technology of rapid genome sequencing in the hope of improving the well-being of critically ill newborn babies.

time-read
1 min  |
December 2022
Hong Kong uses novel computation methods to develop COVID-19 hotspot map
BioSpectrum Asia

Hong Kong uses novel computation methods to develop COVID-19 hotspot map

A research team led by Hong Kong Baptist University (HKBU) has launched the Hong Kong COVID-19 Hotspot Map which allows the intuitive visualisation of real-time and dynamic geographic distribution of COVID-19 cases in Hong Kong.

time-read
1 min  |
December 2022
Korea designs novel skinattachable auditory sensor
BioSpectrum Asia

Korea designs novel skinattachable auditory sensor

A research team at the Department of Chemical Engineering, Pohang University of Science and Technology (POSTECH), South Korea has developed a skin-attachable microphone sensor that clearly detects voices even in harsh noisy environments.

time-read
1 min  |
December 2022
Kyowa Kirin announces change in leadership position
BioSpectrum Asia

Kyowa Kirin announces change in leadership position

Kyowa Kirin, a Japan-based Global Specialty Pharmaceutical company, has announced the appointment of Abdul Mullick, President, Kyowa Kirin International (KKI), to a new role in the global organisation, as Vice Chief International Business Officer, reporting to the Global President.

time-read
1 min  |
December 2022
Healthify Me picks Stanford's Dr Shebani Sethi as Chief Medical Officer
BioSpectrum Asia

Healthify Me picks Stanford's Dr Shebani Sethi as Chief Medical Officer

In a first for a healthtech startup in India, Bengaluru-based HealthifyMe has announced the appointment of Dr Shebani Sethi as its consulting Chief Medical Officer (CMO).

time-read
1 min  |
December 2022
CARsgen names Dr Sylvie Peltier as SVP of global regulatory affairs
BioSpectrum Asia

CARsgen names Dr Sylvie Peltier as SVP of global regulatory affairs

China-based startup CARsgen Therapeutics Holdings has announced that Dr Sylvie Peltier has been appointed as Senior Vice President (SVP) of Global Regulatory Affairs of the company.

time-read
1 min  |
December 2022
Smith+Nephew opens academy in Singapore
BioSpectrum Asia

Smith+Nephew opens academy in Singapore

Smith+Nephew, the global medical technology company, has announced the opening of Smith+Nephew (S+N) Academy Singapore, a major medical education and digital innovation centre covering the Asia-Pacific region.

time-read
1 min  |
December 2022